Synthesis, characterization, antimicrobial activity, and QSAR studies on substituted oxadiazaboroles

Heterocyclic Aminoboron Compounds as Antituberculosis Agents

(2014) Lachlan S. Campbell-Verduyn et al.   HETEROATOM CHEMISTRY

Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial

(2013) James E. Ross et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

An assessment of the genetic toxicology of novel boron-containing therapeutic agents

(2013) Vic Ciaravino et al.   ENVIRONMENTAL AND MOLECULAR MUTAGENESIS

Synthesis and antibacterial evaluation of a novel tricyclic oxaborole-fused fluoroquinolone

(2012) Xianfeng Li et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Design and synthesis of 3,5-disubstituted boron-containing 1,2,4-oxadiazoles as potential combretastatin A-4 (CA-4) analogs

(2012) Bhaskar C. Das et al.   TETRAHEDRON LETTERS

Synthesis and evaluation of novel α-amino cyclic boronates as inhibitors of HCV NS3 protease

(2010) Xianfeng Li et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis

(2009) Tsutomu Akama et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Quantitative structure–activity relationship (QSAR) for a series of novel cannabinoid derivatives using descriptors derived from semi-empirical quantum-chemical calculations

(2008) Antonio M. Ferreira et al.   BIOORGANIC & MEDICINAL CHEMISTRY